These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25257528)

  • 41. Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia.
    Yan P; Frankhouser D; Murphy M; Tam HH; Rodriguez B; Curfman J; Trimarchi M; Geyer S; Wu YZ; Whitman SP; Metzeler K; Walker A; Klisovic R; Jacob S; Grever MR; Byrd JC; Bloomfield CD; Garzon R; Blum W; Caligiuri MA; Bundschuh R; Marcucci G
    Blood; 2012 Sep; 120(12):2466-74. PubMed ID: 22786882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype.
    Estécio MR; Maddipoti S; Bueso-Ramos C; DiNardo CD; Yang H; Wei Y; Kondo K; Fang Z; Stevenson W; Chang KS; Pierce SA; Bohannan Z; Borthakur G; Kantarjian H; Garcia-Manero G
    Br J Haematol; 2015 May; 169(3):344-51. PubMed ID: 25612675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
    Nishioka C; Ikezoe T; Yang J; Yokoyama A
    PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD81 is a candidate tumor suppressor gene in human gastric cancer.
    Yoo TH; Ryu BK; Lee MG; Chi SG
    Cell Oncol (Dordr); 2013 Apr; 36(2):141-53. PubMed ID: 23264205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation.
    Ørskov AD; Treppendahl MB; Skovbo A; Holm MS; Friis LS; Hokland M; Grønbæk K
    Oncotarget; 2015 Apr; 6(11):9612-26. PubMed ID: 25823822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia.
    Li T; Gao R; Xu K; Pan P; Chen C; Wang D; Zhang K; Qiao J; Gu Y
    Drug Resist Updat; 2024 Sep; 76():101120. PubMed ID: 39053383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
    Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
    Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cancer‑testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo.
    Zhou J; Li Y; Yao Y; Wang L; Gao L; Gao X; Luo X; Li J; Jiang M; Zhou M; Wang L; Yu L
    Mol Med Rep; 2013 Nov; 8(5):1549-55. PubMed ID: 24002123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia.
    Thépot S; Lainey E; Cluzeau T; Sébert M; Leroy C; Adès L; Tailler M; Galluzzi L; Baran-Marszak F; Roudot H; Eclache V; Gardin C; de Botton S; Auberger P; Fenaux P; Kroemer G; Boehrer S
    Cell Cycle; 2011 Jul; 10(14):2323-30. PubMed ID: 21654193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).
    Kuipers JE; Coenen EA; Balgobind BV; Stary J; Baruchel A; de Haas V; de Bont ES; Reinhardt D; Kaspers GJ; Cloos J; Danen-van Oorschot AA; den Boer ML; Marschalek R; Meyer C; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Blood; 2011 Jan; 117(3):928-35. PubMed ID: 21045196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias.
    Lasa A; Carnicer MJ; Aventín A; Estivill C; Brunet S; Sierra J; Nomdedéu JF
    Leukemia; 2004 Jul; 18(7):1231-7. PubMed ID: 15103390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
    Paul TA; Bies J; Small D; Wolff L
    Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.